Effects of combined gentamicin and furosemide treatment on cochlear ribbon synapses

Liana Sargsyan1, Alisa P Hetrick1, Jessica G Gonzalez1

  • 1Research Service, VA Loma Linda Healthcare System, CA 92357, USA.

Neurotoxicology
|March 5, 2021
PubMed

Insights

Combined gentamicin and furosemide treatments, at low doses, promote synaptic plasticity in the cochlea. This indicates potential for auditory synaptopathy without significant hair cell damage.

Area of Science:

  • Ototoxicology
  • Neuroscience
  • Auditory Science

Background:

  • Aminoglycoside antibiotics and loop diuretics are known ototoxic agents.
  • Their combined use can lead to rapid, irreversible hair cell damage.
  • The impact on cochlear ribbon synapses and auditory synaptopathy is not fully understood.

Purpose of the Study:

  • To investigate the effects of combined gentamicin and furosemide treatment on cochlear ribbon synapses.
  • To determine if this combination induces auditory synaptopathy.
  • To assess the relationship between synaptic changes and hair cell damage.

Main Methods:

  • C57BL/6 mice were treated with varied doses of gentamicin and furosemide.
  • Auditory brainstem responses (ABR) and distortion product otoacoustic emissions (DPOAE) were measured.
  • Electrophysiologic and morphological analyses were employed to assess cochlear and synaptic integrity.

Main Results:

  • Combined treatment induced cochlear damage and synaptic ribbon reorganization.
  • Significant reduction in ribbon density was observed only after substantial outer hair cell loss.
  • Low-dose treatment elevated ABR wave I amplitude and ribbon density, but without significant correlation.

Conclusions:

  • Combined gentamicin and furosemide treatment at doses below those causing hair cell damage primarily induces synaptic plasticity.
  • This suggests a potential for reversible changes at the auditory nerve synapse.
  • The findings differentiate between synaptic plasticity and permanent synaptic loss in ototoxicity.